Skip to main content
Clinical Trials/IRCT20200531047614N2
IRCT20200531047614N2
Recruiting
Phase 3

The effects of melatonin supplementation compared with placebo on ultrasound findings and metabolic profiles in obese children and adolescents with nonalcoholic fatty liver disease

Kashan University of Medical Sciences0 sites66 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
on alcoholic fatty liver disease (NAFLD).
Sponsor
Kashan University of Medical Sciences
Enrollment
66
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Obese children and adolescents diagnosed with nonalcoholic fatty liver.
  • Patients aged 10\-18 years old.

Exclusion Criteria

  • Taking any antioxidant and/or anti\-inflammatory supplements within 3 months prior to the enrollment.
  • Patients with infectious and autoimmune diseases
  • Hypersensitivity to the study medication.

Outcomes

Primary Outcomes

Not specified

Similar Trials